Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.06. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
04.06. | BioHarvest Sciences Inc.: BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles | 158 | Newsfile | Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
21.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
21.05. | BioHarvest enters fragrance market with new AI-assisted project | 3 | Investing.com | ||
21.05. | BioHarvest steigt mit KI-unterstütztem Projekt in den Duftmarkt ein | 2 | Investing.com Deutsch | ||
BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln | |||||
21.05. | BioHarvest secures new CDMO contract to develop plant-based fragrance compound | 3 | Seeking Alpha | ||
21.05. | BioHarvest Sciences Inc.: BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound | 300 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
16.05. | BioHarvest outlines path to $11M-$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline | 2 | Seeking Alpha | ||
15.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Reports First Quarter 2025 Financial Results | 304 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
12.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
12.05. | BioHarvest Sciences Inc.: BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company | 238 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
05.05. | BioHarvest stock gains on new Buy rating, $15 target from Craig-Hallum | 4 | Investing.com | ||
01.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
01.05. | BioHarvest Sciences Inc.: BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time | 231 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
08.04. | H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target | 1 | Investing.com | ||
01.04. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
31.03. | BioHarvest Sciences GAAP EPS of -$0.17 misses by $0.03, revenue of $7.3M beats by $0.06M | 2 | Seeking Alpha | ||
31.03. | BioHarvest Sciences Inc.: BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results | 402 | Newsfile | Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 MillionCDMO Division Secures Anchor Partnership... ► Artikel lesen | |
17.03. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
17.03. | BioHarvest Sciences Inc.: BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time | 322 | Newsfile | Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 26,715 | +1,66 % | Kriegserklärung an Pharmaindustrie!? Bayer, Novo Nordisk und Geheimtipp PanGenomic Health | Hat US-Gesundheitsminister Robert F. Kennedy Jr. der traditionellen Pharmaindustrie den Krieg erklärt? In diese Richtung äußerte sich jedenfalls der ehemalige Trump-Pressesprecher und heutige Podcaster... ► Artikel lesen | |
PFIZER | 20,795 | +0,34 % | Depot Verdoppler mit Künstlicher Intelligenz: Novo Nordisk, PanGenomic Health und Pfizer zünden 2025 den Profit-Turbo | Lauf BlackRock Health Sciences steht der globale Gesundheitssektor 2025 vor einem beispiellosen Aufschwung. Nach Jahren der Volatilität durch die Pandemie soll die Branche jetzt die höchsten Gewinnzuwächse... ► Artikel lesen | |
MERCK KGAA | 112,05 | +0,36 % | MilliporeSigma and "Abbott Elementary" Inspire Students' Curiosity With Hands-On STEM | NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up with... ► Artikel lesen | |
AURORA CANNABIS | 3,620 | -0,41 % | Aurora Cannabis Inc (3): Aurora Cannabis expands compassionate pricing program | ||
CANOPY GROWTH | 1,070 | +0,56 % | Canopy Growth Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,356 | +2,27 % | Tilray Brands, Inc.: Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke | SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem... ► Artikel lesen | |
BRISTOL-MYERS SQUIBB | 39,960 | +0,24 % | Bristol Myers wins favorable FDA label updates for cell therapies Breyanzi and Abecma | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
DERMAPHARM | 34,750 | 0,00 % | EQS-DD: Dermapharm Holding SE: Dr. Andreas Eberhorn, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
24.06.2025 / 16:45... ► Artikel lesen | |
CRONOS GROUP | 1,614 | -1,34 % | Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders | TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 8,400 | -5,15 % | EyePoint Pharmaceuticals, Inc. - 8-K, Current Report | ||
INCYTE | 60,88 | +0,59 % | Incyte-Aktie: Kurs mit wenig Bewegung (59,3484 €) | Wenig Kursbewegung gegenwärtig bei dem Anteilsschein von Incyte . Das Wertpapier notiert derzeit bei 68,44 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich zur Stunde... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 1,220 | +2,52 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen |